Skip to main content
logo

Novo Nordisk A/S (ETR:NOV)

Germany flag Germany · Delayed Price · Currency is EUR
41.85
+0.49 (1.17%)
Aug 1, 2025, 10:49 PM CET

Novo Nordisk Revenue

Novo Nordisk had revenue of 78.09B DKK in the quarter ending March 31, 2025, with 19.49% growth. This brings the company's revenue in the last twelve months to 303.14B, up 24.11% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

Revenue (ttm)
303.14B DKK
Revenue Growth
+24.11%
P/S Ratio
4.52
Revenue / Employee
3.92M DKK
Employees
77,349
Market Cap
183.53B EUR

Revenue Chart

* This company reports financials in DKK.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Siemens Healthineers AG23.38B
Merck KGaA21.32B
Bayer Aktiengesellschaft46.58B
Fresenius SE & Co. KGaA22.13B
Fresenius Medical Care AG19.49B
Sartorius Aktiengesellschaft3.47B
Fielmann Group AG2.33B
Carl Zeiss Meditec AG2.17B
Revenue Rankings

Novo Nordisk News

More News